![](https://news.europawire.eu/wp-content/uploads/2022/01/novartis-campus-basel-e1641813163342-144x144.jpg)
(IN BRIEF) Novartis has confirmed its plans for a full Spin-off of its Sandoz business, with trading of new Sandoz Group AG shares and ADRs scheduled to begin on October 4, 2023. This comes after receiving shareholder approval and key … Read the full press release